Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of cyclopofol with sufentanil for adult gastroscopy
ChiCTR2200062764Phase 4Not yet recruiting
- Sponsor
- Tongde Hospital of Zhejiang Province
- Start
- Aug 2022
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol in None, sponsored by Tongde Hospital of Zhejiang Province. Primary endpoint: ED90 of cyclopofol combined with sufentanil in adult gastroscopy. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2200062764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062764.